The stepped price system covers about 35 percent of all medicine packages sold on prescription to Norwegian customers. It is therefore vital that Norway receives stable deliveries of these medicines.
A united industry, through Apotekforeningen, Legemiddelindustrien, pharmaceutical wholesalers and generic suppliers, has proposed a raft of measures aimed at avoiding a situation where generic supplies withdraw from the Norwegian market. The authorities have responded by implementing the following measures:
- All stepped prices will rise from 15 May to 14 August 2020 inclusive.
15 percent price increase
The measure assumes that the wholesalers accept suppliers increasing the prices of contract products sold subject to stepped price terms and conditions. Prices will rise by 15 percent compared with contract prices pre-corona crisis.
Suppliers will be notified of the new measure.
